Prostate Cancer - Results from #1800

A qualitative study on healthcare professional and patient perspectives on nurse-led virtual prostate cancer survivorship care. November 10, 2023

Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. November 10, 2023

Mapping the contributions of dyadic approaches to couples' psychosocial adaptation to prostate cancer: a scoping review. November 10, 2023

The quality of YouTube videos on radiotherapy and prostatectomy for prostate cancer. November 10, 2023

Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Update. November 10, 2023

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. November 10, 2023

The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. November 10, 2023

The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics. November 10, 2023

Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System November 9, 2023

Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. November 9, 2023

AI-powered radiomics: revolutionizing detection of urologic malignancies. November 9, 2023

Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. November 9, 2023

Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. November 9, 2023

Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study. November 9, 2023

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer November 8, 2023

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment? November 8, 2023

Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study. November 8, 2023

Association of Frailty and Complications Following Prostate Biopsy: Results from a Population-Based, Privately Insured Cohort. November 8, 2023

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer. November 8, 2023

AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. November 8, 2023

Page 91 of 1435